BioSpace News Archive

Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention.

Nexus Spine, a developer of biomechanically-advanced solutions for spinal pathologies, today announced that its Tranquil ™ interbody fusion technology has reached 5,000 implantations.

UroGen Pharma to Host Thought Leader Webinar on UGN-102 and Non-Muscle Invasive Bladder Cancers.

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy ® for Pre-Treated HR+/HER2- Metastatic Breast Cancer.

Surmodics, Inc. (NASDAQ:SRDX) today announced that 6-month data from its SWING first-in-human (FIH) study of the company’s Sundance™ Sirolimus drug-coated balloon (DCB) was shared at the Amputation Prevention Symposium (AMP) in Lugano, Switzerland.

ReddyPort, a NIV-focused medical technology company, announced today that US Patent No 11,324,910 has been issued by the US Patent Office covering Positive Pressure Ventilation Appliance Modules and Related Systems and Methods.

The American Academy of Stem Cell Physicians will be hosting its fall Scientific Congress in Chicago, IL, on Oct. 28-30, 2022.

Noven Pharmaceuticals, Inc. today announced that it will present poster data related to its dextroamphetamine transdermal system (d-ATS) for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) at the annual American Academy of Child and Adolescent Psychiatry (AACAP) and Canadian Academy of Child and Adolescent Psychiatry (CACAP) conference October 17-22, 2022.

Royal Philips announced that it has received a coveted gold-level ‘Touchstone Award’ from the Center for Health Design* for the Ambient Experience behavioral health rooms it co-developed with Children’s Medical Center Dallas and social solutions software company Recornect.

Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”) today announced plans to investigate the ability of BWV-201, a Streptococcus pneumoniae vaccine candidate for acute otitis media (“AOM”) prevention, to also protect against non-invasive pneumococcal pneumonia at the World Vaccine Congress in Barcelona.